Technology
About
Paid Pilot
Evidence
Homepages
Home A
— Clarity
Metrics and proof up front, designed to build trust instantly.
Home B
— Approach
Showcasing our methodology, process, and consulting system.
Home C
— Scale
Built to highlight case studies, growth, and global reach.
services
Services A
— Modular Systems
Frameworks that combine strategy, design, and execution.
Services B
— Data Signals
Turning raw inputs into predictive insights and decisions.
Services C
— Delivery Engines
Execution cycles engineered for measurable outcomes.
Contact
Contact A
— Direct
For fast answers and straightforward communication.
Contact B
— Open
We’re always curious to hear what you’re building.
Contact C
— In Touch
Built for thoughtful conversations and lasting partnerships.
Homepages
About
Team, values, and the mission driving Modulabs forward.
Blog
All perspectives in one place — from research to case studies.
Pricing
Clear tiers with transparent value and outcomes.
Careers
Shape the future of consulting with a growing team.
Contact
Technology
Evidence
About
Pilot Program
Funding
Request Test Case
Contact
Request Test Case
FUNDING & TRANSPARENCY
Funded by Corfo
for transparent,
open science
Our work was supported by Corfo's innovation promotion program, Innova Alta Tecnología. The formalization documents for this agreement are publicly available below, in the spirit of institutional transparency.
1. Convenio de Subsidio Innova Electrónico
Official subsidy agreement with Corfo outlining Innova Alta Tecnología funding terms.
2. Resolución de Subsidio Innova Exenta 02/2025
Government resolution formally authorizing and approving the Innova Alta Tecnología subsidy grant.
3. Recursos Recibidos 2026
Resources Received 2026
4. Carta Notificacion de Subsidio
Subsidy Notification Letter
5. Cumplimiento Ley N° 21.722
Compliance with Law No. 21,722
6. Resolución de Subsidio Innova Exenta 06/2025
Government resolution formally authorizing and approving the Innova Alta Tecnología subsidy grant.
7. Estado de Resultados 2025
MedX’s 2025 income statement detailing monthly revenue, operating expenses, non-operating results, and annual net income.
8. Balance General 2025
MedX’s general balance sheet for the fiscal year ended December 31, 2025, detailing assets, liabilities, losses, and gains.
9. Ficha de Proyecto 2000 UTM
Project disclosure under Article 25 of Chile’s 2026 Budget Law, including objectives, awarded budget, resources received, and governance information.
10. Memoria Anual - Actualización 2025–2026
Annual activity report summarizing MedX’s clinical validation, commercial progress, intellectual property, regulatory roadmap, and outlook for 2025–2026.
